KADCYLA® (ado-trastuzumab emtansine) Preparation & Storage in EBC

Familiarize yourself with KADCYLA® (ado-trastuzumab emtansine) preparation and storage in HER2+ early breast cancer. See Full Safety and Boxed Warnings for more information.

WO2015164665A1 - Methods of treating early breast cancer with

Ado-trastuzumab emtansine (Kadcyla®) » ADC Review

Ado-Trastuzumab Emtansine (Kadcyla)

Clinical Trial Results in EBC KADCYLA® (ado-trastuzumab emtansine)

PDF) Impact of Pertuzumab and Ado-Trastuzumab Emtansine on

Risk-based Approaches for Optimizing Treatment in HER2-Positive

Treatment Schedule for EBC KADCYLA® (ado-trastuzumab emtansine)

Targeted therapeutic options and future perspectives for HER2

These highlights do not include all the information needed to use

Trastuzumab (Intravenous) Including Biosimilars of Trastuzumab